[1]
“Evaluation of Interferon Gamma and Osteopontin levels in Relapsing- Remitting Multiple Sclerosis Patients”, AIMCJ, vol. 2, no. 3, pp. 1–8, Dec. 2025, doi: 10.58564/AIMCJ2.3.2025.228.